Metrics
14 Record Views
- Title
- PROGRESS OF THE PHASE I CLINICAL TRIAL TO EVALUATE LONGEVERON ALLOGENEIC MESENCHYMAL STEM CELLS (LMSCS) AS A POTENTIAL THERAPEUTIC FOR ALZHEIMER'S DISEASE
- Creators
- Anthony A Oliva - Longeveron LLC, Miami, FL, USABernard Baumel - University of Miami Miller School of Medicine, Miami, FL, USAMark Brody - Brain Matters Research, Delray Beach, FL, USAMarc Agronin - Behavioral Health and Clinical Research, Miami Jewish Health Systems, Miami, FL, USAAmy Drouillard - Longeveron LLC, Miami, FL, USAAndrea Pena - Longeveron LLC, Miami, FL, USALisa McClain-Moss - Longeveron LLC, Miami, FL, USASuzanne L Page - Longeveron LLC, Miami, FL, USACarmen Perez - University of Miami Miller School of Medicine, Miami, FL, USAJonathan Landman - University of Miami Miller School of Medicine, Miami, FL, USATequesta Alston - Brain Matters Research, Delray Beach, FL, USASusan Y Bookheimer - UCLA, Los Angeles, CA, USARicardo Castaneda - Miami Jewish Health, Miami, FL, USAJoshua M Hare - Longeveron LLC, Miami, FL, USA
- Publication Details
- Alzheimer's & dementia, Vol.15(7), pp.P586-P586
- Publisher
- Elsevier Inc
- Academic Unit
- Leadership Department; Miller School of Medicine; Interdisciplinary Stem Cell Institute; UMMG Department of Neurology; UMMG Dept of Psychiatry & Behavioral Sciences
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031597966202976